Anondita Medi. sees a credit rating action
TL;DR
What is the total quantum of the corporate guarantee extended to the subsidiary, and how does this specific amount compare to the parent company's existing net worth and total outstanding debt as per the latest standalone balance sheet?
The provided filings and financial data for Anondita do not contain information regarding corporate guarantees extended to subsidiaries, nor do they provide the standalone balance sheet figures required to calculate net worth or total outstanding debt. Consequently, we cannot determine the quantum of such guarantees or perform the requested comparison.
What are the specific terms of the credit facility being guaranteed—specifically the tenor and interest rate—and does the subsidiary have a history of independent credit ratings that would necessitate this parent-level support?
The specific interest rates and tenors for the credit facilities of Anondita Medicare Limited (AML) are not publicly disclosed in the available regulatory or rating filings. The facilities, aggregating to Rs 56.21 Crores, are structured on a joint and several liability basis across multiple group entities, including Anondita Healthcare and Anondita Healthcare and Rubber Products India Pvt Ltd, rather than relying on a traditional parent-level guarantee [1].
Credit Facility Structure and Terms
- Facility Scope: The total bank loan facilities of Rs 56.21 Crores are distributed across several lenders, including IDFC First Bank, Tata Capital Limited, Oxyzo Financial Services Limited, Karur Vysya Bank, and Deutsche Bank [1].
- Liability Basis: The facilities are availed on a joint and several liability basis, meaning all co-applicants are treated as primary borrowers [1].
- Covenants: While specific interest rates and maturity dates are not reported, the sanction terms include standard covenants for such facilities, such as a requirement to maintain a minimum 51% shareholding by the promoters in AML and restrictions on capital withdrawal without prior bank approval [1].
Credit Rating History
There is no evidence of a prior history of independent credit ratings for the subsidiary or the company in the provided context. The rating assigned by Brickwork Ratings in May 2026 is an initial assignment, with the rating history for 2023, 2024, and 2025 marked as "NA" [1].
Analytical Implications
The reliance on joint and several liability among group entities suggests that the credit profile is assessed on a consolidated group basis rather than through individual subsidiary creditworthiness. The absence of prior public ratings is consistent with the company's recent transition into a listed corporate entity, as noted by the rating agency [1]. The current rating of BWR BBB/Stable (Long Term) and BWR A3 (Short Term) reflects the company's established business position and promoter experience, balanced against risks related to its smaller scale, working capital intensity, and dependence on ongoing capacity expansion [1].
How does the parent company's total contingent liability, including this new guarantee, compare to the contingent liability-to-net-worth ratios of comparable mid-cap healthcare providers in the Indian market?
The contingent liability-to-net-worth ratio for Anondita Medi and the identified peer group cannot be calculated, as contingent liability figures are not separately disclosed in the provided financial filings or KPI data.
Evidence We reviewed the financial disclosures and KPI metrics for Anondita Medi and the peer group, including Bajaj Consumer Care, Honasa Consumer, Cupid Limited, Emami Ltd, and Gillette India. While balance sheet metrics such as total equity, total assets, and debt-to-equity ratios are available, contingent liabilities—including guarantees—are not reported for any of these entities in the current dataset [1].
Implication Without the disclosure of off-balance-sheet guarantees or contingent liabilities, it is not possible to quantify the total risk exposure or the impact of new guarantees on the capital structure of these companies. Investors typically look for these figures in the notes to the financial statements to assess potential future cash outflows that are not captured by standard debt-to-equity or net-debt-to-equity ratios.
Limits This assessment is limited by the absence of contingent liability reporting in the provided financial statements. Any analysis of the parent company's risk profile regarding this new guarantee would require access to the specific disclosure notes in the company's audited annual report or subsequent regulatory filings.
Sources
- [1]Current Ratio
Keep digging